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ABSTRACT: There is a pressing clinical need to develop cell-
based bone therapies due to a lack of viable, autologous bone
grafts and a growing demand for bone grafts in musculoskeletal
surgery. Such therapies can be tissue engineered and cellular,
such as osteoblasts, combined with a material scaffold. Because
mesenchymal stem cells (MSCs) are both available and fast
growing compared to mature osteoblasts, therapies that utilize
these progenitor cells are particularly promising. We have
developed a nanovibrational bioreactor that can convert MSCs
into bone-forming osteoblasts in two- and three-dimensional,
but the mechanisms involved in this osteoinduction process
remain unclear. Here, to elucidate this mechanism, we use
increasing vibrational amplitude, from 30 nm (N30) to 90 nm
(N90) amplitudes at 1000 Hz and assess MSC metabolite, gene, and protein changes. These approaches reveal that dose-
dependent changes occur in MSCs’ responses to increased vibrational amplitude, particularly in adhesion and
mechanosensitive ion channel expression and that energetic metabolic pathways are activated, leading to low-level reactive
oxygen species (ROS) production and to low-level inflammation as well as to ROS- and inflammation-balancing pathways.
These events are analogous to those that occur in the natural bone-healing processes. We have also developed a tissue
engineered MSC-laden scaffold designed using cells’ mechanical memory, driven by the stronger N90 stimulation. These
mechanistic insights and cell-scaffold design are underpinned by a process that is free of inductive chemicals.
KEYWORDS: mesenchymal stem cells, nanovibration, mechanotransduction, bioreactor, bone tissue engineering
Bone is the second-most grafted tissue after blood inhumans and is used in a wide range of musculoskeletalsurgeries.1−3 However, the use of autografts from patient
donor sites is limited and has a high incidence of morbidity.1−3
Allograft is therefore widely used but also suffers from a lack of
donor material and is acellular and so lacks biological activity.1−3
Cellular therapies, used in combination with scaffolding
materials, represent a future source of bone graft and
regeneration approaches. As such, a growing number of
mesenchymal stem cell (MSC)-based therapies are in clinical
trial.4 We note that the termMSC is widely used and often refers
to adherent stromal cells, as is typically the case in cell therapies.5
However, here we use the termMSC to more accurately refer to
skeletal stem cells selected from bonemarrow stroma using Stro-
1.6,7 These are a clonogenic population of nonhematopoietic
bone marrow stromal cells that can recreate cartilage, bone,
adipocytes, and hematopoiesis-supporting stroma.6,7
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We have previously reported the development of a nano-
vibrational bioreactor that can stimulate MSC differentiation
toward osteogenesis in two-dimensional (2D)8 or three-
dimensional (3D)9 without the use of defined media, chemicals,
or highly specialized equipment (see supplementary Figure 1 for
an image of the bioreactor). This approach offers significant
advantages because it enables media, standard consumables, and
MSC banks that have already been approved for use to be
utilized. For example, in this study we used 6- and 24-well plates
with our nanovibrational bioreactor by simply attaching them to
a vibrating top-plate with magnets. The use of standard
consumables also enables cells to be cultured in wells with
scaffold materials, such as hydrogels, enabling us to think
beyond just cell manufacture and toward tissue engineering.
The bioreactor employs the reverse piezo effect, in which a
voltage is used to cause a mechanical expansion of a material, in
this case a piezo active ceramic. The piezo ceramics are
sandwiched between a large mass (aluminum block) and the
ferrous top plate (which provides a magnetic interface).10 We
have previously trialled a range of frequencies using this set up,
with a fixed amplitude of 30 nm, and have found 1000 Hz to be
optimal for MSC osteoinduction.8
Despite our ability to induce osteogenesis using this approach,
we know little about how mechanistically nanovibrational
mechanotransduction in MSCs induces osteogenic differ-
entiation. We have previously reported altered cell adhesion
and RhoA kinase (ROCK) activity in MSCs cultured in 2D in
the nanovibrational bioreactor,8 and we have also previously
Figure 1. 3D MSC osteogenesis with N30 and N90 nanostimulation. (A) Collagen gel constructed with 0.8 mg/mL (top) and 1.8 mg/mL
(bottom) (note that both are front views, and the gel diameter was 13 mm before removing from the well). (B) Interferometry showing that 0.8
and 1.8 mg/mL collagen gels vibrate as expected with N30 stimulation (n = 24). (C) Using interferometry, resonance effects were seen at
frequencies >2000 Hz, but no resonance peaks were seen at 1000 Hz, for both 0.8 and 1.8 mg/mL collagen gels (n = 3−5). (D) Interferometry
results for N30 andN90 nanostimulation, showing good fidelity of vibration in the 1.8 mg/mL collagen gel (n = 24). (E) Interferometry showed
a linear voltage−amplitude relationship for both the vibration platform and the 1.8 mg/mL collagen gel (n = 5) between 12 and 27 Vpp. (F) No
resonance frequencies were seen at 1000 Hz at either the center or edge of the 1.8 mg/mL collagen gels (n = 5). (G) Osteogenic marker gene
expression in MSCs, as assessed by qPCR for N90 compared to N30 (or control), after 9 days of culture in 3D nanovibrational stimulation
conditions in 1.8 mg/mL collagen gels. Osteogenic marker gene expression was enhanced in N90 conditions, compared to N30 or control
conditions (d = 2, r = 4, t = 3). (H) Osteogenic transcript expression in N90 conditions in 1.8 mg/mL collagen gels at days 7, 14, and 21 of
culture. (I) Schematic of expression maxima with time (d = 3, r = 4, t = 3). Significance calculated using ANOVA with Tukey multiple
comparison, where * = p < 0.05, ** = p < 0.01, and *** = p < 0.001. Error bars representmeans± SD. The data shows good fidelity and improved
efficacy of 3D nanostimulation with change in gel stiffness and with increased vibration amplitude. Abbreviations: d = number of donors
assessed; r = number of wells tested; and t = technical replicates. Donors are MSCs derived from different donor sources.
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identified TRPV1, transient receptor potential cation channel
subfamily V member 1, as being implicated in 3D nanovibra-
tional osteogenesis.9
We hypothesize that increasing nanovibrational amplitude
will enhance an osteogenic effect and related cell signaling. From
our findings, we propose that increasing the nanovibrational
amplitude that MSCs are exposed to exaggerates the underlying
osteogenic mechanism, allowing us to further dissect MSC
mechanotransduction mechanisms induced by nanovibration.
RESULTS AND DISCUSSION
Optimization of 3D Nanovibrational Cultures. Type I
collagen is a widely used 3D hydrogel scaffold, which we have
previously used in nanovibrational experiments at 0.8 mg/mL
concentration.9 An advantage of this collagen formulation is its
low stiffness (E = ∼26 Pa at 0.8 mg/mL, supplementary Figure
2A), which is well below the 30−40 kPa stiffness required to
drive MSC osteogenesis11,12 and its good biocompatibility as
shown using alamar blue (supplementary Figure 2C; please note
that live−dead staining showing no reduction in cell viability for
N30 is available in ref 9). Importantly for nanovibrational
stimulation, it adheres to the sides of cell culture plates, thereby
providing mechanical integration with the plate. As a hydrogel, it
is incompressible.13 It thus acts as a solid volume when vibrated
in a contained environment, such as the wells of a culture plate,
providing good vibration propagation throughout its volume9
(Figure 1B). However, the action of cells within the collagen gel
can induce the gel to contract from the edge of the well over
long-term osteogenic cultures, which typically take 28 days to
reach mineralization.14,15
In order to overcome this issue, we trialled a 1.8 mg/mL
collagen gel. While this gel formulation is stiffer (E = ∼161 Pa,
supplementary Figure 2A), it remains significantly below the
stiffness required to induce MSC osteogenesis (>20 kPa).11,12 It
was also easier to handle (as shown in Figure 1A), which could
have positive implications in the operating theater, where
surgeons need to remove a cell product from a dish to place into
a patient. Importantly, vibrational fidelity was similar to that of
the 0.8 mg/mL gel, with a 30 nm displacement at the vibration
plate surface inducing 35 nm vibrations in both the 0.8 and 1.8
mg/mL gels, as indicated by laser interferometry (Figure 1B).
Furthermore, little evidence of resonance effect was seen in any
Figure 2. Adhesion and ion channel expression by MSCs when cultured with vibrational amplitude of N30 or N90. (A) Protein array data,
presented as a heatmap. It shows the expression levels of a range of adhesion, extracellular, and ion channel proteins inMSCs cultured in control
conditions (C) and in conditions of N30 and N90 vibrational amplitude, after 9 days of stimulation (d = 2, r = 4, t = 3). Red denotes increased
expression, and blue denotes reduced expression, relative to control. (B, C) Ion channel expression (B), BMP family member’s expression (C,
left), and adhesionmolecule expression (C, right), as assessed by qPCR, for control, N30 andN90 cultures after 9 days of stimulation (d = 2, r =
4, t = 3). (D) qPCR analysis of RUNX2 and OSX expression, with or without ROCK inhibition (Y-27632), for control, N30 and N90 cultures
after 9 days of stimulation (d = 1, r = 4, t = 3). Significance calculated using ANOVAwith Tukeymultiple comparison where * = p < 0.05 and ** =
p< 0.01. Error bars representmeans± SD.Data show that ion channel and extracellularmatrix and adhesion proteins aremore highly expressed
in N90 conditions relative to N30 conditions and that inhibiting ROCK has only a small effect on osteogenesis. Abbreviations, d = number of
donors assessed; r = number of wells tested; and t = technical replicates.
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replicates of the 0.8 and 1.8 mg/mL gels at 1000 Hz driving
frequency (Figure 1C). By looking at collagen-plastic detach-
ment over a longer culture period, we found that while the 0.8
mg/mL gels contracted within a 30 day culture period, with
typical cell seeding of 40,000 MSCs/mL collagen (supple-
mentary Figure 2B), the 1.8 mg/mL gels did not contract until
>70 days when seeded with either 40,000 or 80,000 cells/mL
and exposed to 1000 Hz, 30 nm vibrational stimulation. This
time period extends way beyond the usual duration of our MSC
nanovibration experiments (supplementary Figure 2B).
A key aim of this research was to investigate if a larger
amplitude can induce more pronounced changes to allow us to
infer cell mechanism with more clarity. To investigate this, we
selected a second amplitude of 90 nm, which we used in addition
to a previously tested amplitude of 30 nm (referred to as N30
and N90, respectively). For both gels, we observed a slight
increase in amplitude, relative to that of the top plate, from 30 to
∼35 nm with N30 and from 90 to ∼100 nm with N90 (Figure
1D). We note that the voltage−amplitude relationship was
linear between 12 and 27 Vpp (voltage peak-to-peak, the region
in which we operate) in the 1.8 mg/mL collagen gel, as it was
when measured on the bioreactor top plate (Figure 1E), again
demonstrating the fidelity of the system.
We next assessed the resonance using interferometry. At 1000
Hz, the bioreactor generated reliable displacements without
resonance problems at the edge and the center of the 1.8 mg/mL
hydrogels (Figure 1F). Osteogenic marker expression was also
assessed by qPCR. After 9 days of MSC stimulation in 3D, using
1.8 mg/mL gels and N30 stimulation, alkaline phosphatase
(ALP) expression was detected (Figure 1G). However,
osteogenic stimulation was significantly more pronounced
following N90 stimulation, with several osteoblast markers
expressed after 9 days, including ALP, runt related transcription
factor 2 (RUNX2), osterix (OSX), osteonectin (ON),
osteopontin (OPN), and osteocalcin (OCN) (Figure 1G).
Peroxisome proliferator activated receptor γ (PPARγ) ex-
pression, an adipocyte marker, was also assessed to gauge
whether the nanovibrational effect was osteospecific. No
induction of PPARγ was observed with N30 or N90 stimulation
at 9 days of culture (Figure 1G). Alamar blue staining showed
that there were no cytotoxic effects of N30 or N90 stimulation in
the 1.8 mg/mL collagen gels or in the control conditions with/
without osteogenic media (supplementary Figure 2C).
Higher Amplitude Stimulation Increases Osteogene-
sis and Ion Channel Expression. We next assessed how
nanostimulation at N30 and N90 conditions affected the
expression of adhesions and ion channels that have been
previously implicated inN30-stimulatedMSC osteogenesis.9 To
do so, we used a protein array containing a range of receptors
and channels. Using this array, we observed the upregulated
expression of β1, 3, and 5 integrins after 9 days ofMSC culture in
both N30 and N90 conditions (Figure 2A). These integrins
function as receptors for a wide range of extracellular matrix
(ECM) proteins. A range of collagens were also upregulated in
N30- and N90-stimulated MSCs (Figure 2A); we note that
integrin β1 is used by cells to attach to collagens.16 Bone
morphogenetic protein 2 (BMP2) receptor BMPR1 was also
upregulated following nanovibrational stimulation (Figure 2A).
Most interestingly, however, was the pattern of ion channel
expression by MSCs. In agreement with previous results,9 N30
conditions stimulated the expression of transient receptor
potential cation channel subfamily V member 1 (TRPV1)
(Figure 2A). However, under N90 conditions, TRPV1wasmore
highly expressed, as were TRPA1, Piezo1 and 2, and potassium
channel subfamily K member 2 (KCNK2) (Figure 2A), each of
which are mechanosensitive ion channels that can be opened by
stretch, for example, by membrane deformation17,18 or by
myosin contracting the cytoskeleton.19,20 They also reportedly
transduce high-frequency vibrational forces, such as in the
ear21,22 (we note that 1000 Hz is in the audible range).
Moreover, KCNK2 (also known as TREK1) has been associated
with low-frequency osteoinduction of MSCs via magnetic
twisting cytometry.23
Figure 3. Untargetedmetabolomic analysis ofMSCs cultured in N30 andN90 stimulation conditions. (A) Lipid heatmaps ofMSCs after 1 and 2
weeks of nanostimulation at N30 and N90 amplitudes. (B) PCA of MSC lipid data after 1 and 2 weeks of culture in N30 and N90
nanostimulation conditions, compared to control. (C)Observedmetabolite changes in ROS pathways following 1 week of culture under N30 or
N90 conditions. (D) Schematic of potential pathways derived from the heatmap data (d = 1, r = 4, t = 1). The data indicate the activation of ROS
and redox-balancing pathway occurs in MSCs cultured in conditions of increasing nanostimulation amplitude. Abbreviations: d = number of
donors assessed; r = number of wells tested; and t = technical replicates.
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It is notable that Piezo1 is down-regulated in N30 conditions
and upregulated in N90 conditions, compared to control. This
might be a time-dependent phenomenon or a gated phenom-
enon, wherein higher levels of stimuli are more likely to activate
threshold-dependent mechanisms. Indeed, the force-dependent
activation of Piezo1 has been compared to a switch;24 for
example, Piezo1 has been linked to ATP signaling in MSCs in a
threshold-dependent manner.25
We assessed protein levels with the protein array and
transcript levels with qPCR at the same time points. Ion
channels showed less change at the transcript level than at the
protein level, with N90 stimulation producing the greatest
upregulation of TRPV1, Piezo2 and calcium sensing receptor
(CaSR) expression, and of the downstream target, extracellular
signal related kinase 1 (ERK1). Among the assessed BMP
signaling family members, only the expression of small mothers
against decapentaplegic 1 (SMAD1) was induced by N90
stimulation (Figure 2C, left), while the assessed collagen genes
were not expressed by MSCs cultured with N30 or N90
stimulation (Figure 2C, right). Inhibiting cytoskeletal tension
Figure 4. Metabolomic analysis of MSCs cultured with N30 and N90 nanostimulation. (A) Observation of ROS-based pathways. (B, C)
Metabolites involved in ROS after MSCs were cultured for 7 days of under control, N30 and N90 conditions (d = 1, r = 4, t = 1). (D) DCF-DA
flow analysis, showing that ROS levels increase with nanostimulation amplitude, reaching significance followingMSC stimulation at N90 (d = 3,
r = 3, t = 1). (E) qPCR analysis of RUNX2 andOSX expression inMSCs after 9 days of culture under N30 or N90 conditions. Bothmarkers were
upregulated following N90 stimulation in this donor cell line, with ROS inhibition having little effect on their expression (d = 1, r = 4, t = 3). (F)
(top) Ingenuity pathway analysis of metabolite networks induced by N30 stimulation, showing the predicted upregulation of ERK1/2
(osteogenic commitment) and SOD (ROS) and the predicted repression of Akt and NFκB (REDOX balancing). (bottom) N90 stimulation is
predicted to result in the activation of all these pathways (d = 1, r = 4, t = 1). For (D and E), error bars represent means ± SD. Significance
calculated using ANOVAwith Tukey multiple comparisons, where * = p < 0.05, ** = p < 0.01, and *** = p < 0.001. The data indicate that MSCs
generate ROSwhile committing to osteogenesis and that, when the signal becomes stronger, the cells also activate REDOX balancing pathways.
They also indicate that ROS itself is not a driver of osteogenesis. Abbreviations: d = number of donors assessed; r = number of wells tested; and t
= technical replicates.
ACS Nano www.acsnano.org Article
https://dx.doi.org/10.1021/acsnano.0c03130
ACS Nano XXXX, XXX, XXX−XXX
E
with the ROCK inhibitor, Y-27632, produced only a subtle loss
of osteogenesis, with only N30 conditions indicating that
intracellular tension is important for cell responses to 3D
nanovibrational stimulation (Figure 2D).
From these results, we propose that vibrational amplitude at
N90 provides a more powerful osteogenic cue than does N30
and that ion channel expression is particularly increased by this
higher amplitude.
Reactive Oxygen Species and Nanovibrational Stim-
ulation. To investigate further the cellular pathways that are
altered by nanovibrational stimulation in MSCs, we took an
untargeted metabolomics approach. Cells were lysed after
culture for 1 or 2 weeks in control, N30 or N90 conditions, and
then analyzed by liquid chromatography (LC)-orbitrap mass
spectrometry (MS).26 Heatmap analysis and principle compo-
nent analysis (PCA) revealed that lipids are the largest
differentially regulated metabolite group (Figure 3A) and that
the metabolome of N30 and N90 cultured cells MSCs diverged
from each other and the control group (Figure 3B).
After 1 week of culture, the metabolites of major respiration-
related pathways, including glycolysis, the pentose phosphate
pathway, TCA cycle, oxidative phosphorylation (OXPHOS), L-
aromatic amino acid, long-chain polyunsaturated fatty acids
(LC-PUFAs), and β-oxidation were typically upregulated to
Figure 5. Nanostimulation at N90 upregulates inflammatory markers in MSCs. (A) Increased expression of TNFα, ERK1/2, and JNK1 in MSCs
cultured with N90 stimulation for 9 days, as assessed by qPCR (d = 1, r = 4, t = 3). (B) Inhibition studies with qPRC for RUNX2 and osterix
(OSX) showed that p38MAPK inhibited RUNX2 expression and TNFα enhanced OSX expression with N90 stimulation compared to N30 (d =
1, r = 4, t = 3). (C) IL-6 and NFκB show increased expression to day 14 of culture and decreased expression to day 21, as assessed by qPCR;
increased expression was more persistent for N90 stimulation (d = 3, r = 4, t = 3). (D) IL-1 showed no detectable expression with either N30 or
N90 stimulation, as assessed by ELISA (d = 1, r = 4, t = 1). Error bars represent means± SD, significance calculated using ANOVA with Tukey
multiple comparison, where * = p < 0.05, ** = p < 0.01, and *** = p < 0.001 (note that blue and red asterisks show the significant difference of
N30 and N90 to control, while black asterisks represent significant difference between N30 and N90). The data show a very low-level
inflammatory response that is not detectable at the protein level. Abbreviations: d = number of donors assessed; r = number of wells tested; and t
= technical replicates.
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differing levels by N30 and N90 conditions (Figure 3C). N90
conditions produced the most differentially regulated responses
relative to unstimulated control conditions. The responses to
N90 were therefore used to build a pathway map. The pathways
that were affected include inflammation and reactive oxygen
species (ROS) and the pentose phosphate pathway (PPP),
which acts to balance oxidative stress27 (Figure 3D). Together,
these data indicate that nanovibrational stimulation triggers an
energetic response in cells, as evidenced by increased glycolytic
and tricarboxylic acid (TCA) cycle metabolite levels28 (Figure
3D). Metabolite pathways were also analyzed using ingenuity
pathway analysis (IPA). The IPA analysis further supported
these results. After 1 week of nanovibrational stimulation,
metabolic pathways were upregulated in both N30 and N90
conditions, relative to control conditions, with greater
upregulation seen in N90 conditions (supplementary Figure
3). By 2 weeks of nanostimulation, pathways were mostly down-
regulated in N30 conditions, but remained predominantly
upregulated in N90 conditions (supplementary Figure 4). This,
again, suggests that MSC osteogenesis stimulated by nano-
vibration is an energetic process and that the greater the
stimulus, the greater the observed effects on the cell. We also
note, from increases in ROS- and PPP-related metabolites, that
redox balancing might also be potentially occurring to counter
oxidative stress (Figure 3D).
To follow up the observation that redox balancing potentially
occurs in response to nanostimulation, we again used IPA to
analyze the metabolomic data. By looking at oxidative stress
(Figure 4A), we observe pathways being increasingly activated
in N90 relative to N30 conditions. Looking at the individual
metabolites inferred as contributing toward oxidative stress, we
observe the same metabolites forming the network, but being
more highly activated in N90 conditions (Figure 4B,C).We next
used 2′-7 dichlorodihydrofluorescein diacetate (DCF-DA) flow
cytometry to measure ROS. While a small increase was noted in
N30 conditions, relative to the control, this increase became
statistically significant in N90 conditions (Figure 4D).
Previous studies have linked small increases in ROS to
enhanced osteogenesis; however, large increases in ROS are also
linked to the suppression of osteogenesis.29−31 To investigate
this issue in our experimental system, we used N-acetyl cysteine
to inhibit ROS (Figure 4E) and then assessed RUNX2 and OSX
expression in MSCs after 9 days of culture by qPCR. Our results
show that while RUNX2 and OSX were expressed at a low level
in N30 conditions, both markers were significantly upregulated
in N90 conditions, again showing that enhanced osteogenesis
occurs with the larger amplitude. In addition, little change in
marker expression was seen in response to ROS inhibition,
indicating that ROS do not have a detrimental effect on
osteogenesis and are a likely by-product, rather than a driver, of
osteogenesis.
Using IPA activity predictor, where metabolite networks are
linked to biochemical signaling hubs, some consistencies and
some similarities and some differences in signaling could be
observed between N30 and N90 stimulation (Figure 4F). ERK
1/2 is predicted to be upregulated, as are the superoxide
dismutase (SOD) pathways for both N30 and N90 stimulation.
ERK 1/2 stimulation is widely reported to be important for
MSC osteogenesis, as it is implicated in the phosphorylation and
activation of RUNX2, the osteogenic master transcription
factor.32−34 SOD is used by cells to counter balance the effects of
ROS,35 and so this finding fits with our observations of increased
ROS production and PPP activation (Figure 4B,D). Interest-
ingly, the results of stimulation at N90 also implicate the nuclear
factor kappa-light-chain-enhancer of activated B cells (NFκB)
and protein kinase B (Akt) pathways, which are involved in cell
survival and in preventing apoptosis and are both linked to
antioxidant function.36,37
Inflammation and Nanovibrational Stimulation. In-
creased levels of ROS lead to inflammation,38 and a small degree
of inflammation is implicated in the natural bone healing
process, while high levels of inflammation prevent osteo-
genesis.39 Given this, we hypothesized that inflammation
might be observed in MSCs following their culture under N90
conditions. To explore this, we assayed the expression of the
inflammatory markers, interleukin 6 (IL-6), NFκB, and tumor
necrosis factor (TNFα), by qPCR after 9 days of N90 culture, as
well as that of two mitogen activated protein kinases (MAPKs),
ERK (which is involved in cell proliferation and osteo-
genesis)32−34 and of c-jun n-terminal kinase (JNK, which is
also implicated in osteogenesis32 but is better known for being
activated by ROS or inflammation to mediate cytokines and
apoptosis).40 We observed increased expression of TNFα, ERK,
and JNK after 9 days of culture and N90 stimulation compared
to unstimulated control (Figure 5A).
We next inhibited these inflammatory pathways and p38
MAPK (which is activated by cell stress and is involved in
apoptosis and differentiation control)41 and assessed the
expression of the osteogenic markers, RUNX2 and OSX, in
MSCs cultured under N30 and N90 stimulation conditions. It
was seen that compared to N30, N90 osteogenesis (RUNX2)
was enhanced by p38 MAPK inhibition and reduced (OSX) by
TNFα inhibition (Figure 5B).
Looking at the pro-inflammatory cytokine (IL-6)42 and the
inflammation response factor (NFκB)36 at days 7, 14, and 21 of
MSC culture, we observed that the expression of these
inflammatory mediators tracked each other; their expression
increased to day 14 and then reduced (Figure 5C), most notably
with N90. This suggests that nanostimulation induces an
inflammatory response that is then countered by the cells and
that the magnitude of this response scales with amplitude. We
used ELISA to assess the levels of the major proinflammatory
cytokine, IL-1β,43 and found that it was undetectable at N30 or
N90 conditions, with concentrations below the sensitivity of the
standard curve (Figure 5D). This demonstrates that the
inflammatory response we observed is small rather than
constituting real inflammation, at a level more likely to be
positive in terms of bone formation.39
Our unpublished data suggest thatMSCs from∼1 in 20 donor
samples do not respond to nanovibrational stimulation. We
looked at NFκB, which is linked to osteogenesis in MSCs, from
one of these donors. In this donor, there was little evidence of
osteogenesis having occurred after N30 or N90 stimulation,
based on the expression of RUNX2, OSX, and OPN after 9 days
of culture, (supplementary Figure 5A). However, when NFκB
was inhibited with TPCA-1, the expected increase in these
osteogenic markers was observed (supplementary Figure 5A).
Furthermore, nanovibration resulted in the decreased expres-
sion of NFκB in direct proportion to vibration amplitude
(supplementary Figure 5B). We thus speculate that the
inflammatory background of the donor and/or dysregulation
of NFκB might increase or decrease the osteogenic capacity of
individual MSCs.
Tissue Engineering Using Nanovibration. These data
demonstrate that increasing nanoscale amplitude can enhance
osteogenesis through a low-level ROS/inflammatory axis in 3D
ACS Nano www.acsnano.org Article
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Figure 6. Design of a gel-sponge composite for nanovibrational stimulation. (A) A freeze-dried collagen sponge (left) showing its pore structure
by SEM (right). (B) Schematic of the composite gel’s fabrication. The sponge is held down with a weight, while the cell/gel mixture is poured
over it and sets. After the weight is removed, more collagen is poured on. At a user-defined time, the cell-containing collagen gel can be released
from the well edges and allowed to contract onto the sponge to form an easy to handle construct. (C) Gel constructs, containing 4, 10, and 20×
104 MSCs/mL, were stimulated for 7 days, and then the gels detached from the well. All gels contracted onto the sponge within 2 days, and the
sponge prevented further contraction (d = 1, r = 4, t = 1). (D) Interferometry testing of vibrational transmission in the composite gel. A linear
voltage amplitude relationship was seen both at the sponge and gel positions (top). Looking at points across the gel-sponge composites (middle
and bottom), slightly higher amplitudes were observed at the sponge position compared to the gel at N90 stimulation, with up to 20 nm variance
observed (n = 3−6). (E) Increasing vibration frequencies were assessed using interferometry. The sponge induced resonant frequencies at
∼1250 Hz. At 1000 Hz, however, little evidence of resonant effects was observed (n = 3, GS; gelsponge composite, G; gel area, S; sponge area).
(F) MSC migration in the gel toward the sponge, shown at day 6 (precontraction) and at day 10 (post contraction). Movement toward the
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MSC cultures. Here, we look to see if these changes hold as we
develop a composite more suitable to being used for tissue
engineering.
The gels used in this report are very soft (∼26−161 Pa) and
thus problematic to handle. Exploiting this osteogenic effect in a
more structurally stable scaffold is of vital importance for the
Figure 6. continued
sponge increased with contraction (S = sponge location). (G) Cell velocity, however, decreased postcontraction (d = 1, r = 1, t = 10). (H)
Histology of gel-sponge composite sections showingMSCmigration into the gels (red = 10, green = 10, blue = 10; g = gel, s = sponge). The data
show that this fabricated gel-sponge composite can facilitate cell migration and the application of nanovibrational stimulation. Abbreviations: d
= number of donors assessed; r = number of wells tested; and t = technical replicates.
Figure 7. Osteogenesis and mechanical memory of gel-sponge constructs. (A) Osteogenic marker expression analysis by qPCR of MSCs
cultured for 1, 2, and 3 weeks in the composite gel without gel detachment (d = 2, r = 4, t = 3). (B) IL-6 and NFκB inflammatory marker
expression by qPCR of MSCs cultured for 1, 2, and 3 weeks in the composite gel without gel detachment. The markers are initially upregulated
and then rapidly return to control levels (d = 2, r = 4, t = 3). (C) Schematic of the expression profiles of inflammatory and osteogenic markers in
MSCs cultured under N90 stimulation. (D) Schematic of the stimulation, detachment, and experimental termination regimens for mechanical
memory analysis. They were as follows: 1 week of nanostimulation followed by gel detachment from the sides of the well; 1 week of contraction
(1NS/2W) for 4, 10, and 20 × 104 MSCs per mL of collagen, using N30 and N90 and 2 weeks of nanostimulation followed by gel detachment
from the sides of the well; and 2 weeks of contraction (2NS/4W) for 4× 104 MSCs per mL of collagen using N30 and N90. (E) Using N30, very
little evidence of mechanical memory post-cessation of nanostimulation and subsequent contraction was observed. However, following N90
stimulation, evidence of mechanical memory was seen using 20 × 104 MSCs per mL for the 1NS/2W regime with enhanced ALP expression.
Mechanical memory was also observed using N90 for the 2NS/4W regime with 4× 104 MSCs per mL with enhanced expression of RUNX2 and
ON (d = 1, r = 4, t = 3). Error bars represent means± SD, significance calculated using ANOVA with Tukey multiple comparison where * = p <
0.05, ** = p < 0.01, and *** = p < 0.001 (note that where applicable, blue and red asterisks show the significant difference of N30 and N90 to
control, while black asterisks represents significant difference between N30 and N90). The data show that MSC osteo-differentiation occurs
within the composite constructs and that, with N90, mechanical memory can be used to enable the production of a contracted, easy to handle,
tissue-engineered product.
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clinical translation of this technology. However, there are some
constraints. The scaffold needs to be physically integrated with
the well plate, and thus collagen gels are useful as they are
biocompatible and attach to the sides and bottom of culture
dishes (unless the cells detach the gel through contraction).
Collagen gels are also highly hydrated. Water is incompressible,
meaning that when constrained, such as in a culture plate well, it
acts as a solid object.13 Hydrogels are mainly water, and this
means that the cells experience vibration in all parts of the gel, as
we demonstrate on top of the gels using interferometry (Figure
1D).
We thus decided to generate a composite gel using a collagen
sponge to provide rigidity while maintaining biocompatibility.
Insoluble collagen was freeze-dried to form a highly porous
structure (pore size 227.74 ± 72.93, measured using Feret’s
diameter),44 which was ∼4 mm high and ∼11 mm in diameter
(Figure 6A), and has an elastic modulus of 1.08 ± 0.29 MPa
(Zwick-Roell compression testing). The acellular scaffolds were
held in place with a small weight, while 2.5 mL of MSC-
containing neutralized collagen solution was poured over them.
This sets the scaffolds within the wells of a 12-well plate and
provides a 3D MSC source (Figure 6B). Once the gel is set and
the scaffold set in place, the weight is removed and a small
amount of fresh collagen is added to complete the gel (Figure
6B).
In order to make scaffolds that are easier to handle for
potential clinical applications, we utilized the adherent proper-
ties of collagen to allow for vibration fidelity. We did so by
vibrating the gels for a period and then allowing the contractile
properties of the cells in the collagen to pull the gels onto the
sponge. To test this, gels were seeded with 4, 10, and 20 × 104
cells per mL of MSCs and cultured with/without N30 and N90
stimulation for 7 days. Gels were then released from the sides of
the wells and contraction observed. All gels in all conditions
contracted on to the sponge within 2 days, with 10 × 104 and 20
× 104 MSCs contracting the gels more than 4 × 104 MSCs
(Figure 6C). Next, interferometry was used to observe gel
vibrational response to N90 input. We observed that vibration
was higher in the well center (over the gel) at just over 100 nm
and was lower at the well edges at 80−90 nm (Figure 6D);
acceptable vibration fidelity was seen.
Using N90 conditions with 4 × 104 MSCs/mL, we looked for
resonant frequency at 1000 Hz. While measuring at the center
(sponge, S) and edge (gel, G) of the gel-sponge composite, no
resonance effects were seen at increased amplitude of just over
100 nm (Figure 6E), enabling us to proceed with 1000 Hz
stimulation.
We also looked at MSC migration into the gel composite at 4
× 104 MSCs/mL without N90 stimulation. MSC migration,
while always toward the sponge, became more targeted post-
contraction (day 10) compared to pre-contraction (day 6)
(Figure 6F). The velocity of MSC migration, however,
decreased postcontraction (Figure 6G). Histology at day 12
confirmed that cell migration into the gels had occurred (Figure
6H).
We next moved to consider osteogenesis and also mechanical
memory (or mechanical priming) of MSCs in the gel-sponge
composites. This was in order to check first that the composites
could be used with nanovibrational stimulation and then second
to see if the composites could be vibrated for shorter-term
cultures with prolonged osteogenesis (i.e., with memory of the
initial vibration). Thus, in the gel-sponge composites, 4 × 104
MSCs/mL with/without N30 and N90 stimulation were
assessed for osteogenic markers by qPCR after 1, 2, and 3
weeks of vibration without gel detachment. We observed the
increased expression of pro-osteogenic markers at both N30 and
N90 stimulation, and this increase was greater at N90
stimulation (Figure 7A). The expressions of IL-6 and NFκB
were also tested to assess the inflammatory response of MSCs
during nanostimulation in the composite. Although IL-6 and
NFκB were initially expressed, their expression quickly reduced
to background levels (Figure 7B), concurring with our low-level
inflammation-osteogenesis hypothesis (Figure 7C).
Finally, we assessed two different culture regimes for
contracting the gel onto the sponge to enable the manufacture
of free-floating scaffolds with good handling properties. The first
used 1 week nanostimulation before gel detachment (osteogenic
markers were upregulated in the MSCs in the composites)
(Figure 7A) to produce free floating cell-composite scaffolds.
Another week of culture was then allowed to promote full
contraction onto the scaffold, giving a 2 week production
timeline (1:1). This was performed with 4, 10, and 20 × 104
MSCs per mL of collagen. The second regime used 2 weeks of
nanostimulation before gel detachment and a further 2 weeks of
culture (2:2), giving a 4-week production timeline for the free-
floating cell composites. For N30, very little osteogenesis was
observed with either the 1:1 or 2:2 regimes (Figure 7E).
However, with N90, osteogenic transcriptional changes were
observed for the 1:1 regime that used the highest level of cell
loading (20 × 104) and with the longer 2:2 regime that used the
lower cell loading level (4 × 104) (Figure 7E).
SUMMARY
By increasing the amplitude of nanostimulation, we have been
able to better dissect the cellular mechanisms of nanovibrational
osteogenesis in MSCs. Many 2D osteogenesis studies have
highlighted the central role of intracellular tension. In this 3D
study, we can see clear changes in the regulation of integrin
receptors and of ECM components, such as collagen (Figure
2A). We also observed the differential expression of known
integrin-linked osteogenic pathways, such as ERK (Figure 2B).
In all cases, stimulating MSCs with N90 produced a more
marked transcriptional and protein-level response. However,
reducing intracellular tension via ROCK inhibition did not
significantly impact osteogenesis in our system (Figure 2D). Our
results thus suggest that while adhesion is modulated and
contributes to osteogenesis, it is not the central driver.
Several ion channels were also upregulated during nanovibra-
tionally stimulated MSC osteogenesis. Ion channel expression
and the number of channels showing enhanced expression were
linked to increasing amplitude (Figure 2A,B). For example, at
the protein level, the TRPV1 cation channel was upregulated in
N30 conditions, while and TRPV1, TRPA1, Piezo1 and 2 cation
channels, L-type Ca2+ channel, and the KCNK2 potassium
channel were upregulated in N90 conditions. The TRP cation
channels are typically associated with temperature and pain
sensing and can be activated via inflammatory mediators, such as
IL-1, IL-6, and ROS,17,45,46 which we assess in this work. TRP
and piezo channels have also been implicated in vibrational
mechanotransduction, such as in sterocillia signaling in
hearing.22 In fact, both TRP and piezo channels have also
been linked to cytoskeletal organization, YES associated protein
(YAP, a known osteogenic mechanoregulator),47,48 and BMP-2
regulated osteogenesis.24,49,50 This ties in well with previous
findings that 3D osteogenesis can be disrupted with TRPV1
inhibitors9 and adds to the body of evidence suggesting that
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these ion channels have wide ranging effects in cellular
mechanotransduction. Again, subtle results observed at N30
were more evident at N90.
The transduction of higher frequency sound waves into
biologically relevant signals is a poorly understood mechanism.
However, we postulate that cells might convert higher frequency
stimuli in constant excitatory responses. For example, at low
frequency, Piezo1 behaves like a bandpass filter with a center
frequency at around 10Hz.51 At higher frequencies, the in-phase
peak response disappears, and a “tonic” current remains, which
in turn increases with frequency. This model predicts that for a
1000 Hz stimulus, a sustained tonic current is expected, which
might be comparable with a single stimulus peak response when
the number of stimulated channels exceeds several hundred.51
This behavior suggests the presence of an underlying molecular-
lever mechanism that is able to transduce the mechanical
stimulus with a frequency-dependent efficiency. While the
specific origin of this mechanism is not yet clear, it is noteworthy
that many mechanosensitive ion channels have been found to
have common structural features, and it is likely that this is the
root for a broad and concerted cell mechanosensitivity.52
Untargeted metabolomics analysis led us to look at ROS and
inflammation. Subtle increases in ROS and redox-balancing
pathways, such as PPP and SOD, were activated in response to
nanostimulation at N90 (Figures 3C and 4). Similarly, pro-
inflammatory and inflammation-mediating pathways were
transcriptionally activated (Figure 5). However, pro-inflamma-
tory cytokines were not detected at the protein level following
MSC stimulation at N90 (Figure 5D). Our metabolomic data
also reveal hallmarks of increased energy demand during MSC
differentiation, which concurs with the literature showing that
increased oxidative phosphorylation occurs in MSCs under-
going differentiation to produce more ATP.36,53,54 From these
findings, we propose that this energy demand drives increased
levels of ROS and thus some of themarkers of inflammation. It is
well-known that ROS is generated via increased electron
transport chain activity.55 However, MSCs counter this increase
in potentially damaging pathways.31 Inhibiting ROS had only a
small effect on osteogenesis (Figure 4E) and likely illustrates
that ROS production and inflammation are byproducts of
osteogenesis rather than drivers of it. Early stage, low level
increases in ROS and inflammation are seen in the earliest stages
of bone fracture repair−in the inflammatory phase, also known
as fracture hematoma formation.39 From our data, we speculate
that this inflammation is a byproduct of bone cell stimulation.
Together, our metabolomic and biochemical data, and those
already published, lead us to propose a model for nanovibra-
tional stimulation pathways, in which respiration/energy are
linked to ROS and inflammation balancing responses and
MAPK signaling to drive osteogenesis (Figure 8). However,
more work is required to fully elucidate these proposed
pathways.
Our data also allow us to speculate that over a threshold
amplitude, nanovibrational stimulation could become detri-
mental to cells as they struggle to balance the increasing levels of
ROS and inflammation. Furthermore, our analysis of a
nonresponding donor MSC line indicates that inflammatory
background might be important in the selection of donor
material for orthopedic cell manufacture (supplementary Figure
5).
Figure 8. A model of the mechanisms that contributes to nonvibrational MSC stimulation illustrating that respiration is linked to ROS and
inflammation balancing responses and MAPK signaling to drive osteogenesis. Abbreviations: AMPK = AMP-activated protein kinase, AKT =
protein kinase B (PKB), BCL2 = B-cell lymphoma 2, C-Wnt = canonical Wnt, COX = cyclooxygenase, FOXO = forkhead box class O, JAK =
Janus kinases, LOX = lipoxygenase, mTOR=mammalian target of rapamycin, NADPHoxidase = nicotinamide adenine dinucleotide phosphate
oxidase, NC-Ca2+ = noncanonical Wnt/calcium pathway, NC-PCP = noncanonical planar cell polarity pathway, NOS = nitric oxide synthase,
OXPHOS = oxidative phosphorylation, PKC = protein kinase C, pOSX = phosphorylated osterix, pSTAT3 = signal transducer and activator of
transcription protein 3, RANKL = receptor activator of nuclear factor kappa-B ligand, SMAD1/5 = small mothers against decapentaplegic
homologue 1/5, andWnt5a = wingless-related integration site. Line description, red line; expected high-level expression, orange line; expected
low-level expression, blue line; phenotype expression, solid line; predicted pathways, dotted line; theoretical pathways.
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Finally, our study explored the effects of both an increased
N90 amplitude on MSC osteogenesis and also the generation of
a sponge-gel composite that is easier to handle. We assessed
MSCs cultured in this gel composite for markers of osteogenesis
and inflammation and observed enhanced osteogenesis inMSCs
cultured under N90, relative to N30 conditions, and also some
initial expression of IL-6 and NFκB that quickly reduced. This
lends further support to the hypothesis that low-level
inflammation occurs in nanovibration-enhanced osteogenesis.
We also investigated when we could allow the gels to contract
onto the sponge to minimize manufacturing time for use in the
bioreactor and found that 2 weeks of N90 treatment provide the
most optimal time.
CONCLUSIONS
In this study, we demonstrate the important contribution of
amplitude to the nanovibrational stimulation of osteogenesis in
MSCs. We find that an amplitude of N90 produces increased
osteogenesis, relative to an amplitude of N30, and use these
different responses to investigate subtle changes in adhesion,
tension, ion channel regulation, ROS, and inflammation in the
osteogenic MSC response. Using our bioreactor, we provide
insights into the low-level ROS and inflammatory responses that
are typically seen with osteogenesis both in culture, and in the
clinic, resulting from the energetic demands of differentiation.
We confirm these findings in a bioengineered 3D osteogenic
cellular composite, which works with our bioreactor and
provides both an enhanced osteogenic environment and
handlability.
METHODS
Cell Culture. Stro-1 selectedMSCs from adult human bone marrow
(BM) with informed consent from Southampton General Hospital.
MSCs were cultured in Dulbecco’s modified essential medium
(DMEM; Sigma) supplemented with 10% fetal bovine serum (FBS;
Sigma), 1% (v/v) L-glutamine (200 mM, Gibco), 1% sodium pyruvate
(11 mg/mL, Sigma), 1% MEM NEAA (amino acids, Gibco), and 2%
antibiotics (6.74 U/mL penicillin-streptomycin, 0.2 μg/mL fungizone;
Sigma). MSCs were cultured in an incubator set at 37 °C with 5% CO2
environment and subcultured to passage 2−3 before use. Culture media
was changed every 3 days.
Hydrogel Preparation. 0.8 and 1.8 mg/mL collagen hydrogels
were prepared using rat tail collagen type I (2 and 5 mg/mL, First link,
UK). 10 × DMEM (First link, UK) and FBS (Sigma) were added as a
cell supplement. 0.1 M sodium hydroxide (Fluka, UK) was used for pH
titration to achieve a pH of 7.7−8.0 judged by universal litmus paper
and phenol red indicator. After pH titration, Stro-1 selectedMSCs were
added in to the hydrogel mixture (final cell concentration was 4 × 104
cells per mL of hydrogel) and decanted as 2.5 mL pregels into 6- or 12-
well plates. Gelation followed in a 37 °C incubator for 30 min.
Bioreactor Set up. The nanovibrational bioreactor incorporating
piezo actuators (Thru-ring actuators; P-010.00H, Physik Instrumente,
Germany) was used to stimulate cell cultures. A laptop, as signal
generator, was connected to the amplifier (Linn amplifier, Sneaky DS,
UK) transferring an electrical signal to the nanovibrational bioreactor
causing piezo expansion. Selected nanovibrational stimulation (NS)
frequencies in a.flac file type were operated onKinsky software (Version
4.3.14), using as a file control panel. To construct the culture plate-
bioreactor apparatus, adhesive magnetic sheets (3M, UK)were adhered
to the bottom of 6- or 12-well plates (Corning, USA) and attached on
the platform of the bioreactor.
Freeze-Dried Collagen Sponge Preparation. To prepare the
collagen sponges, a 5% weight of bovine tendon powder (Collagen
Solutions, UK) was used. 0.001 M of HCl at pH 3 was added and then
homogenized (TissueRuptor, Qiagen) on ice. The mixed composites
were then molded in polystyrene cell culture inserts (0.4 μm
polyethylene terephthalate (PET) membrane, 12-well plate diameter,
Greiner bio-one, Austria) and in turn frozen at−80 °C for 10 h. Freeze-
drying was performed at −110 °C with a vapor pressure at 0 mbar, for
20 h (VirTis, SP industries, USA). Freeze-dried collagen sponges were
sterilized by UV light exposure for 1 h.
Collagen-Hydrogel Sponge Composite Preparation. To
prepare the composites, sponges were placed at the center of 12-well
plates and were weighed down by placing a sterile screw nut on top of
the sponges. 1.8 mg/mL collagen hydrogels were prepared, and 2.5 mL
of hydrogel with MSCs was poured around the sponges. Gelation was
allowed at pH 7.7−8.0 in a 37 °C incubator. Following the cell-hydrogel
gelation, 0.5 mL of secondary hydrogels (1.8 mg/mL) without cells
were aliquoted on top of the composite to fill any gaps. The composites
were then transferred for stimulation on the NS bioreactor. When the
stimulation time ended, the composites were detached from the culture
wells by spatula, allowing contraction before removal for further
analysis.
Scanning Electron Microscopy. The samples were prepared for
SEM using critical point drying and sputtering. The samples were
mounted onto SEM stubs using double-sided conductive tape and silver
paint. They were then coated with gold/palladium (approximately 10−
20 nm) using a SEM coating system (Q150T ES, Quorum, UK). The
samples were viewed on a JEOL6400 SEM running at 10 kV. Porosity
diameter was analyzed by ImageJ (free download from NIH).
Composite Contraction Measurement and Time Lapse
Microscopy. In order to monitor the hydrogel contraction for the
composites without NS, the percentage of the hydrogel contraction
compared to the initial surface area was measured from a top view. The
surface areas were measured and analyzed by ImageJ software. To
evaluate cell migration, composites were cultured for 6 days
precontraction and 10 days postcontraction. The composites were
then imaged using a 10× objective lens at 120 s intervals for 24 h at 37
°C. Cell velocity and migration directions were analyzed using imageJ
plugin (manual tracking) and chemotaxis and migration tool (Ibidi).
Cryosection and Immunostaining. After composites were
stimulated with NS, the samples were fixed in 4% formadehyde and
infused in 30% sucrose in PBS for cryoprotection overnight at 4 °C. The
samples were then transferred to embeddingmolds, and optimal cutting
temperature (O.C.T.) embedding compound (Tissue-Tek, Sakura)
was aliquoted to cover the samples. The samples were then frozen in
liquid nitrogen and kept at−80 °C. The frozen samples were sliced into
60 mm-thickness sections and attached onto adhesive slides (9597,
Tissue-Tek, Sakura, Netherlands). Immunofluorescent staining was
then carried out. Samples were rinsed with 1 × PBS and fixed with
fixative at 37 °C for 15 min. After that, permeabilization buffer was
added and incubated at 4 °C for 5 min. Samples were then blocked with
1% BSA in 1 × PBS at 37 °C for 5 min. Primary antibody (P-myosin
light chain 2, cell signaling, 3671S, rabbit, 1:50) and rhodamine-
phalloidin (Invitrogen, Thermo Fisher, 1:500) diluted in 1% BSA in 1×
PBS were added and incubated at 37 °C for 1 h. Samples were then
washed with 1 × PBS/0.5% Tween-20 for 3 times (5 min each).
Biotinylated secondary antibody (antirabbit; Vector Laboratories,
USA, 1:50) diluted in 1% BSA in 1 × PBS was added and incubated at
37 °C for 1 h. Samples were washed again with 1 × PBS/0.5% Tween
for 3 times. Streptavidin-FITC (Vector Laboratories, USA, 1:50)
diluted in 1%BSA in 1× PBS was incubated at 4 °C for 30min. Samples
were washed for 3 times. A small drop of 4′,6-diamidino-2 phenylindole
(DAPI, Vectashield) was placed onto the samples and covered with
coverslips. FITC/TRITC channel images were taken (Olympus, US)
operated on Surveyor software version 9.0.1.4 (Objective Imaging,
UK). Images were processed using ImageJ (Version 1.50g, USA) and
Photoshop CS4 (Adobe, version11 extended, Ireland).
Interferometric Measurement. 0.8 or 1.8 mg/mL collagen
hydrogels were prepared. The hydrogel nanovibration was measured
by laser interferometric vibrometer (wavelength = 632.8 nm, CW
power; 5 mW; SIOS, Meβtechnik GmbH, Germany). To reflect the
laser beam, 3 ×3 mm of reflective tape was placed on the hydrogels
surface underneath 1.5 mL of media. The vibration distance was
analyzed using INFASVibro 1.8.4 software (SIOS,Meβtechnik GmbH,
Germany).
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Rheology. To investigate the viscoelastic properties of hydrogels, a
modular compact rheometer (MCR 302, Anton Paar, Austria)
equipped with parallel plates of 25 mm diameter was used.
Measurements were performed at a temperature of 23 °C, under a
constant normal force and gap size both ranging from 0.1 to 0.3 N and
from 1.4 to 2 mm, depending on the samples, respectively. Initial strain
sweep tests at a constant frequency of 10 rad/s were performed to
determine the range of linear response of the hydrogels. Then, the
hydrogels’ linear viscoelastic properties were measured by means of
frequency sweep tests performed with a constant strain amplitude (of
ca. 1% for most of the samples) and frequencies ranging from 100 to 0.1
rad/s.
AlamarBlue Assay. Four ×104 cells/mL of Stro-1 selected MSCs
were prepared in hydrogels or composites and stimulated for 1 and 2
weeks. Samples were washed with warm 1 × PBS. 10% (v/v) of
AlamarBlue resazurin (Bio-Rad, Watford, UK) was diluted in phenol-
red free media (D5030, Sigma). After incubation at 37 °C and 5% CO2
for 5 h, the supernatant containing the taken up AlamarBlue was
pipetted and transferred into 96-well plates. A microplate reader
(Clariostar, BMG Labtech, Germany) was used to detect light
absorbance at wavelengths of 570 and 600 nm. The percentage of
AlamarBlue reduction was calculated as per ref 56.
Quantitative Polymerase Chain Reaction with Reverse
Transcription. To assess gene expression changes, 4 × 104 cells/mL
of hydrogel were prepared for qRT-PCR. Samples were removed from
the bioreactor and transferred to falcon tubes. 2.5 mg/mL of
collagenase (Sigma-Aldrich, UK) was added and incubated for 1.5 h
to digest the collagen hydrogels. Trizol (Life Technologies) and
chloroform (Sigma-Aldrich, UK) were then added with ratio 5:1 in
order to purify nucleic acids. An RNA extraction kit (RNeasy extraction
Kit, Qiagen) was used to purify RNA. The concentration of purified
RNA was measured by spectrophotometer (Nanodrop 2000c, Thermo
scientific, USA). cDNA was then synthesized using the QuantiTect
Reverse Transcription Kit (Qiagen). The cycling temperature in each
process is shown in Table 1. Forward and reverse primers for qRT-PCR
are shown in Table 2. GAPDH, a house-keeping gene, was used as
internal control of the analysis. SYBR Green dye was used to target
synthesized cDNA (Quantifast SYBRGreen I, Qiagen). Real-time PCR
was then performed (7500 Real Time PCR system, Applied Biosystem,
USA). 2−ΔΔCT method was used for interpretation.57
Inhibitor Studies. Four ×104 cells/mL of Stro1 selected MSCs in
1.8 mg/mL collagen hydrogels were stimulated with N30 and N90 for 9
days. Inhibitors, which were diluted in basal media to working
concentration, were added at day 2 (list of inhibitors and used
concentration are shown in Table 3). Culture media with diluted
inhibitor was changed every 2 days.
Protein Antibody Microarrays. To manufacture the arrays,
commercial antibodies (Table 4) were buffer exchanged into PBS and
quantified by bicinchoninic acid (BCA) assay. Antibodies were diluted
to print concentration in PBS and printed in six replicates on Nexterion
H amine reactive hydrogel-coated glass slides (Schott AG, Mainz,
Germany) using a SciFLEXARRAYER S3 piezoelectric printer
(Scienion, Berlin, Germany) under constant humidity (62% ± 2%) at
20 °C. Each feature was printed using ≈1 nL of diluted antibody via an
uncoated 90 μm glass nozzle with eight replicated subarrays per
microarray slide. After printing, slides were incubated in a humidity
chamber overnight at room temperature to facilitate complete
conjugation. The slides were then blocked in 100 × 10−3 M
ethanolamine in 50 × 10−3 M sodium borate, pH 8.0, for 1 h at room
temperature. Slides were washed in PBS with 0.05%Tween 20 (PBS-T)
three times for 2 min, each wash followed by one wash in PBS, dried by
centrifugation (470 × g, 5 min), and then stored with desiccant at 4 °C
Table 1. Thermal Cycler Protocol for cDNA Synthesis
reaction temperature (°C) times (min)
genomic DNA elimination 42 2
reverse transcription 42 30
inactivation 95 3
Table 2. Primer Sequences Used in qRT-PCR
forward primer reverse primer
ALP ATGAAGGAAAAGCCAAGCAG CCACCAAATGTGAAGACGTG
BMP2 CCCACTTGGAGGAGAAACAA AGCCACAATCCAGTCATTCC
CaSR CTACGCACCAGAACTCCCTG CTGTAACAGTGCTGCCTCCA
COL1A1 CCATGTGAAATTGTCTCCCA GGGGCAAGACAGTGATTGAA
ERK1 CCCTAGCCCAGACAGACATC GCACAGTGTCCATTTTCTAACAGT
ERK2 TCTGCACCGTGACCTCAA GCCAGGCCAAAGTCACAG
GAPDH TCAAGGCTGAGAACGGGAA TGGGTGGCAGTGATGGCA
IL-6 GATGAGTACAAAAGTCCTGATCCA CTGCAGCCACTGGTTCTGT
Integrin β5 CTGTGGTCGGTAGCATCCTC GGATCGCTCGCTCTGAAACT
Integrin β1 GTGCAATGAAGGGCGTGTT GTTGCACTCACACACACGACA
JNK1 GGGCAGCCCTCTCCTTTA CATTGACAGACGACGATGATG
JNK2 GAAAGAAGCAAGAATGGTGTTGT GAGAAGGAGTGGCGTTGCTA
NFκB CAGCTGGCTGAAGATGTGAA GTGTTTTGGAAGGAGCAGGA
NFκB CAGCTGGCTGAAGATGTGAA GTGTTTTGGAAGGAGCAGGA
OCN CAGCGAGGTAGTGAAGAGACC TCTGGAGTTTATTTGGGAGCAG
OSN AGAATGAGAAGCGCCTGGAG CTGCCAGTGTACAGGGAAGA
OPN AGCTGGATGACCAGAGTGCT TGAAATTCATGGCTGTGGAA
osterix GGCAAAGCAGGCACAAAGAAG AATGAGTGGGAAAAGGGAGGG
PPARγ TGTGAAGCCCATTGAAGACA CTGCAGTAGCTGCACGTGTT
Piezo1 TCGCTGGTCTACCTGCTCTT GGCCTGTGTGACCTTGGA
Piezo2 CCCGGAGTTTGAAAATGAAG CAGTGCCTCTTCTGAATCAATTT
RUNX2 GGTCAGATGCAGGCGGCCC TACGTGTGGTAGCGCGTGGC
SMAD1 CCACTATAAGAGAGTAGAAAGCCCTGT AAGTTACGGAACTGAGCTAAGAGG
SMAD5 GGGTGCCATGGAGGAACTGGA AATCCGGCCAGCGCCAAACA
TNFα CAGCCTCTTCTCCTTCCTGAT GCCAGAGGGCTGATTAGAGA
TRPA TGGACACCTTCTTCTTGCATT TCTTCTCCATTAGCTCAATTTGG
TRPV1 AGAGTCACGCTGGCAACC GGCAGAGACTCTCCATCACAC
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until use. Antibody microarrays were verified to remain active for at
least 2 weeks after printing, and all incubations were carried out within
that time frame.
Four ×104 cells/mL of Stro-1 selected MSCs in 1.8 mg/mL collagen
hydrogels were stimulated with N30 and N90. After stimulation for 1
and 2 weeks, hydrogel samples were digested with collagenase. Total
protein was quantified using micro-BCA kit (Pierce, Thermo Fisher).
Initially, one labeled sample was titrated (2.5−15 μg mL−1) for optimal
signal-to-noise ratio, and all samples were subsequently incubated for 1
h at 23 °C at 9 μg mL−1 in Tris-buffered saline (TBS; 20 × 10−3 m Tris-
HCl, 100 × 10−3 m NaCl, 1 × 10−3 m CaCl2, 1 × 10−3 m MgCl2, pH
7.2) with 0.05% Tween 20 (TBS-T). All microarray experiments were
carried out using three replicate slides. Alexa Fluor 555 labeled MSC
lysates (10 μg mL−1) were incubated in two separate subarrays on every
slide to confirm retained antibody performance and printing,
respectively. After incubation, slides were washed three times in TBS-
T for 2 min per wash, once in TBS, and then centrifuged dry. Dried
slides were scanned immediately on an Agilent G2505 microarray
scanner using the Cy3 channel (532 nm excitation, 90% photo-
multiplier tubes (PMT), 5 μm resolution), and intensity data were
saved as.tif files. Data were normalized to the mean of three replicate
microarray slides (subarray-by-subarray using subarray total intensity, n
= 3, 18 data points). β-actin was used as internal protein control.
Heatmaps were generated by Hierarchical Clustering Explorer v3.0.
Metabolomics. Stro-1-selected MSCs seeded with 4 × 104 cells/
mL density in 1.8 mg/mL collagen hydrogels were stimulated with N30
and N90. After 1 and 2 weeks NS, the gels were homogenized on ice,
and metabolites were then extracted using a chloroform/methanol/
water (1:3:1 ratio) extraction buffer. Samples were agitated on a shaker
at 4 °C for 1 h and in turn centrifuged at 13,000× g at 4 °C for 5 min.
Hydrophilic interaction liquid chromatography-mass spectrometry was
performed (Dionex, UltiMate 3000 RSLC system, Thermo Fisher
Scientific, Hemel Hempstead, UK) using a ZIC-pHILIC column (150
mm × 4.6 mm, 5 μm particle size, Merck Sequant). The data sets were
processed using XCMS (peak picking), MzMatch (filter and grouping),
and IDEOM (post processing filtering and identification). Metab-
oanalyst was used to generate heatmaps and PCA analysis. KEGG
database and Ingenuity Pathway Analysis (IPA) software were used for
metabolomic pathway analysis.
Reactive Oxygen Species Measurement. Stro-1-selected MSCs
seeded with 4 × 104 cells/mL density in 1.8 mg/mL collagen hydrogels
were stimulated with N30 and N90 for 7 days. The samples were
incubated in 2.5 mg/mL collagenase for 1 h and were then centrifuged
at 200 × g for 4 min. Following that, the cell pellets were incubated for
an hour in 2 μM 2′,7′- dichlorodihydrogen-fluorescein diacetate
(H2DCF-DA, Invitrogen) in phenol red free media (Sigma, D5030). In
the positive control group, 500 μMhydrogen peroxide was added. After
incubation, the samples were then centrifuged and resuspended in 250
μL of flow cytometry buffer (2% FBS, 2 mM EDTA in 1 × PBS) and
transferred to 96-well plates. ResuspendedMSCs in 96-well plates were
incubated for 30 min. A signal of H2DCF-DA fluorescein was detected
by using flow cytometry at 492−295 nm for excitation and 517−527
nm for emission.
ELISA of Interleukin-1β. Stro-1-selected MSCs seeded with 4 ×
104 cells/mL density in 1.8 mg/mL collagen hydrogels were
nanostimulated for 7 days. Hydrogels were digested with collagenase
(Sigma-Aldrich, UK). Protein was extracted using RIPA lysis buffer
containing phosphatase and protease inhibitors. Total protein
concentration was quantified using BCA kits (Pierce, ThermoFisher).
Human IL-1β kits (DY201-05, R&D systems) were used for analysis.
Working concentration of reagents (Human IL-1β capture antibody;
840168, Human IL-1β detection Antibody; 840169, Human IL-1β
standard; 840170, Streptavidin-HRP; 893975) were prepared as per
manufacturer’s instructions. To coat the captured antibody onto the
ELISA plate, 100 μL of captured antibody was added into 96-well plate
and incubated overnight at 4 °C. The plate was then washed with
washing buffer (0.05% Tween 20 in 1 × PBS (pH 7.4) 3 times using
multichannel pipettes. 300 μL of reagent diluent (Reagent diluent
concentrate 2, DY995, R&D systems) was added and incubated for 1 h
to block the coated plate. 100 μL of samples and of standards in reagent
diluent (Human IL-1β, 840170) were added and incubated for 2 h at
room temperature. Samples were washed 3 times with washing buffer.
100 μL of streptavidin-HRP was added and incubated for 30 min at
room temperature. Samples were washed 3 times. 100 μL of substrate
solution (1:1 of color reagent A; H2O2 and color reagent B;
tetramethylbenzidine) were added and incubated for 20 min. 50 μL
of stop solution (2NH2SO4, DY994, R&D systems) was added. A
Table 3. List of Inhibitors and Working Concentration
function inhibitors cat no./batch
working
concentration
ERK
inhibitor
U126, Tocris 1144/5 10 μM
P38
inhibitor
SB 202190, Tocris 1264/5 5 μM
JNK
inhibitor
SP600125, Tocris 1496/10 25 μM
NFkB
inhibitor
TPCA-1, Tocris 2559/5 5 μM
TNF alpha R 7050, Tocris 5432/1 2 μM
ROCK
inhibitor
Y-27632, Tocris 1254/35 10 μM
ROS
inhibitor
N-acetyl cysteine,
Sigma-Aldrich
WXBC4028V 10 μM
Table 4. List of Commercial Antibodies Used in the Protein Antibody Microarray
probe concentration(mg/mL) company stock conc(mg/mL) cat. no.
Integrin β1 1 Abcam 3.54 ab134179
Integrin β3 0.1 Abcam 0.17 ab34409
Integrin β5 <0.002 Cell signaling <0.002 D24A5
BMPR1A 1 ThermoFisher 12.71 PA5-11856
Collagen I 1 Abcam 1.72 ab138492
Collagen II 0.25 Abcam 2.29 ab185430
Collagen III 0.5 Abcam 1.03 ab7778
Collagen V 1 Abcam 1.86 ab7046
KCNK2 1 SantaCruz 4.84 sc-11557
KCNK4 0.02 Abcam 0.02 ab81367
TRPA1 0.5 SantaCruz 5.45 sc-32353
TRPV1 1 SantaCruz 6.06 sc-20813
Piezo1 1 SantaCruz 3.13 sc-164319
Piezo2 1 SantaCruz 2.99 sc-84763
L-type Ca2+ 0.5 SantaCruz 4.98 sc-25686
β-actin 1, 0.25, 0.5, 0.75, 2 WAKO 2.56 019-19741
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microplate reader was used to determine the optical density at 450 and
570 nm.
Statistics. To compare the means of samples of more than two
groups, one-way ANOVA with a Tukey post hoc test was used in qRT-
PCR and AlamarBlue assays. Two-way ANOVA with Tukey post hoc
test was used to analyze hydrogel and composites contraction by times.
To compare the data between two groups, two tailed, paired t-tests were
used for AlamarBlue Assay of composites. Two tailed, Mann−Whitney
U tests were used in interferometric measurement and qRT-PCR.
Biological sample populations with four replicates were always used. All
results are shown in mean ± standard deviation with 95%, 99%, and
99.9% of accuracy (* P ≤ 0.5, ** P ≤ 0.01, *** P ≤ 0.001). Replicate
details for each experiment is shown in Table 5.
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